Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
ABSTRACT As of today (7 April 2020), more than 81,000 people around the world have died from the coronavirus disease 19 (COVID-19) pandemic. There is no approved drug or vaccine for COVID-19, although more than 10 clinical trials have been launched to test potential drugs. In an urgent response to t...
Guardado en:
Autor principal: | Fadhl M. Alakwaa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5fa5320a8d244bbd8f6138656f4e9881 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
por: Ahmed A. Al-Karmalawy, et al.
Publicado: (2021) -
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
por: Chiranjib Chakraborty, et al.
Publicado: (2021) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Joana M. O. Santos, et al.
Publicado: (2021) -
Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
por: José Manuel Ezquerra-Aznárez, et al.
Publicado: (2021) -
A Database of Drug Repurposing Clinical Trials in Oncology
por: Pan Pantziarka, et al.
Publicado: (2021)